Arbutus Biopharma Corporation v. Moderna, Inc.
| ARBUTUS BIOPHARMA CORPORATION and GENEVANT SCIENCES, GMBH |
| MODERNA, INC. and MODERNATX, INC. |
| LAMAR SMITH, Congressman |
| THE TEXAS CONSERVATIVE COALITION RESEARCH INSTITUTE, MATTHEW HEPBURN, THE NATIONAL ASSOCIATION OF MANUFACTURERS, AMERICAN INTELLECTUAL PROPERTY LAW ASSOCIATION, EAGLE FORUM EDUCATION & LEGAL DEFENSE FUND, UNITED STATES, NORTHWESTERN UNIVERSITY, ALLIANCE OF U.S. STARTUPS AND INVENTORS FOR JOBS, NOVARTIS PHARMACEUTICALS CORPORATION, ABBVIE INC., BAYER HEALTHCARE PHARMACEUTICALS INC., A28 THERAPEUTICS, INC., JURA BIO, INC., ELUTIA, INC., ELOXX PHARMACEUTICALS, INC., ARCHETYPE THERAPEUTICS, INC., YOKINA BIOME, INC., PAUL R. MICHEL, KATHLEEN M. O'MALLEY, SUSAN G. BRADEN, RONALD A. CASS, DANIEL R. CAHOY, ARTHUR DAEMMRICH, RICHARD A. EPSTEIN, BOWMAN HEIDEN, KEITH N. HYLTON, LAYNE KEELE, JOSHUA KRESH, ADAM J. MACLEOD, GEOFFREY A. MANNE, EMILY MICHIKO MORRIS, Esq., ADAM MOSSOFF, LATEEF MTIMA, KRISTEN OSENGA and BAYH-DOYLE COALITION |
| 26-1581 |
| March 30, 2026 |
| U.S. Court of Appeals, Federal Circuit |
| Patent Infringement (Fed. Qst.) |
Docket Report
RSS Track this Docket
This docket was last retrieved on September 25, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
Filing 87
ORDER filed granting the US's motion [ # 77 ] for leave to participate at oral argument and to enlarge the time allotted for argument. Each side shall receive 20 minutes of argument time. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [1196251] [MJL] [Entered: 09/25/2026 04:57 PM]
|
| Filing 86 NOTICE OF ORAL ARGUMENT. Panel: 2611G. Case scheduled November 5, 2026. Response to Notice of Oral Argument due: 10/05/2026. Please review the attached Notice. The response to notice of oral argument form can be found # here . The Oral Argument Guide can be found # here . Service as of this date by the Clerk of Court. [1194970] [MMA] [Entered: 09/21/2026 03:52 PM] |
| Filing 85 Notice from Appellees Arbutus Biopharma Corporation and Genevant Sciences, GmbH regarding conflicts with oral argument. Service: 09/10/2026 by email, US mail. [1192682] [26-1581] [David Berl] [Entered: 09/10/2026 03:05 PM] |
| Filing 84 The following conflict date submitted by McKaye Lea Neumeister for US has been accepted by the court: 11/02/2026. [1192560] [MJL] [Entered: 09/10/2026 11:26 AM] |
| Filing 83 Notice from Amicus Curiae US regarding conflicts with oral argument. Service: 09/09/2026 by email. [1192302] [26-1581] [McKaye Neumeister] [Entered: 09/09/2026 01:48 PM] |
| Filing 82 6 paper copies of Doc. No. [ # 15 ] received from Amicus Curiae Texas Conservative Coalition Research Institute. [1191948] [AG] [Entered: 09/08/2026 02:41 PM] |
| Filing 81 Amended Entry of Appearance for William M. Jay as counsel for Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 09/03/2026 by email. [1191331] [26-1581] [William Jay] [Entered: 09/03/2026 03:56 PM] |
| Filing 80 Certificate of Interest for Amicus Curiae Texas Conservative Coalition Research Institute. Service: 09/02/2026 by email, US mail. [1190862] [26-1581] [Russell Withers] [Entered: 09/02/2026 10:23 AM] |
| Filing 79 Entry of Appearance for Russell H. Withers as counsel for Amicus Curiae Texas Conservative Coalition Research Institute. Service: 09/02/2026 by email, US mail. [1190859] [26-1581] [Russell Withers] [Entered: 09/02/2026 10:21 AM] |
| Filing 78 **TEXT ONLY** ORDER deferring US's motion [ # 77 ] for leave to participate at oral argument and to enlarge argument time to the assigned merits panel. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [1190809] [MJL] [Entered: 09/02/2026 09:06 AM] |
| Filing 77 MOTION of Amicus Curiae US to allow argument, for additional time at oral argument. Service: 09/01/2026 by email. [1190762] [26-1581] [McKaye Neumeister] [Entered: 09/01/2026 05:13 PM] |
| Filing 76 Notice to Texas Conservative Coalition Research Institute: The record of this case indicates that no Entry of Appearance under FCR 47.3(b) or Certificate of Interest under FCR 47.4(b) has been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [1190450] [MJL] [Entered: 09/01/2026 10:34 AM] |
| Filing 75 **TEXT ONLY** ORDER granting Appellants' motion [ # 74 ] to withdraw Jaime A. Santos as counsel. Service as of this date by the Clerk of Court. This order has been issued without an attached document and is official and binding. [1190441] [MJL] [Entered: 09/01/2026 10:26 AM] |
| Filing 74 MOTION of Appellants Moderna, Inc. and ModernaTX, Inc. to withdraw counsel Jaime A. Santos. Service: 08/31/2026 by email. [1190350] [26-1581] [Jaime Santos] [Entered: 08/31/2026 05:02 PM] |
| Filing 73 6 paper copies of Doc. No. [ # 47 ] received from Amici Curiae A28 Therapeutics, Inc., AbbVie Inc., Archetype Therapeutics, Inc., Bayer HealthCare Pharmaceuticals Inc., Eloxx Pharmaceuticals, Inc., Elutia, Inc., JURA Bio, Inc., Novartis Pharmaceuticals Corporation and Yokina Biome, Inc. [1190106] [CDL] [Entered: 08/31/2026 10:32 AM] |
| Filing 72 6 paper copies of Doc. No. [57], [ # 55 ], [ # 13 ] received from Appellants Moderna, Inc. and ModernaTX, Inc.. [1189703] [AG] [Entered: 08/28/2026 09:41 AM] |
| Filing 70 6 paper copies of Doc. No. [ # 22 ] received from Amicus Curiae National Association of Manufacturers. [1189168] [CDL] [Entered: 08/26/2026 01:57 PM] |
| Filing 69 6 paper copies of Doc. No. [ # 44 ] received from Amicus Curiae Bayh-Doyle Coalition. [1189164] [CDL] [Entered: 08/26/2026 01:55 PM] |
| Filing 68 6 paper copies of Doc. No. [ # 42 ] received from Amicus Curiae USIJ. [1189151] [CDL] [Entered: 08/26/2026 01:30 PM] |
| Filing 67 6 paper copies of Doc. No. [ # 39 ] received from Amicus Curiae Northwestern University. [1189146] [CDL] [Entered: 08/26/2026 01:25 PM] |
| Filing 66 6 paper copies of Doc. No. [ # 33 ] received from Appellees Arbutus Biopharma Corporation and Genevant Sciences, GmbH. [1189126] [CDL] [Entered: 08/26/2026 12:54 PM] |
| Filing 65 6 paper copies of Doc. No. [ # 29 ] received from Amicus Curiae US. [1188372] [CDL] [Entered: 08/24/2026 03:25 PM] |
| Filing 64 REMINDER : All amici counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(c) and Fed. Cir. R. 47.3 to promptly submit an Entry of Appearance (EOA). Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [1188360] [JCW] [Entered: 08/24/2026 03:09 PM] |
|
Filing 63
ORDER filed granting the motion [ # 59 ] to the extent that this appeal will be placed on the November 2026 calendar for oral argument. Service as of this date by the Clerk of Court. [1188325] [LMS] [Entered: 08/24/2026 02:40 PM]
|
| Filing 62 Outstanding paper copies of all briefs and appendices must be submitted within five business days from the date of issuance of this notice. See Fed. Cir. R. 25(c)(3)(A). [1188118] [JCW] [Entered: 08/24/2026 09:21 AM] |
| Filing 61 Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellees Arbutus Biopharma Corporation and Genevant Sciences, GmbH. Service: 08/21/2026 by email, US mail. [1188073] [26-1581] [David Berl] [Entered: 08/21/2026 09:10 PM] |
| Filing 60 RESPONSE of Appellants Moderna, Inc. and ModernaTX, Inc. to Doc No. [ # 59 ]. Service: 08/21/2026 by email, US mail. [1188072] [26-1581] [William Jay] [Entered: 08/21/2026 08:55 PM] |
| Filing 59 MOTION of Appellees Arbutus Biopharma Corporation and Genevant Sciences, GmbH to expedite hearing. Service: 08/21/2026 by email, US mail. [1188070] [26-1581] [David Berl] [Entered: 08/21/2026 08:14 PM] |
| Filing 58 Certificate of Compliance with Fed. Cir. R. 25.1(c)(2) for Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 08/21/2026 by email, US mail. [1188069] [26-1581] [William Jay] [Entered: 08/21/2026 07:54 PM] |
| Filing 57 MODIFIED ENTRY: CONFIDENTIAL APPENDIX FILED by Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 08/21/2026 by email. [1188068]--[Edited 08/24/2026 by JCW - Reason: compliance review complete] [William Jay] [Entered: 08/21/2026 07:45 PM] |
| Filing 56 MODIFIED ENTRY: APPENDIX FILED by Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 08/21/2026 by email. [1188066] --[Edited 08/24/2026 by JCW - Reason: compliance review complete] [William Jay] [Entered: 08/21/2026 07:29 PM] |
| Filing 55 MODIFIED ENTRY: REPLY BRIEF FILED by Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 08/14/2026 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1186581] --[Edited 08/18/2026 by JCW - Reason: compliance review complete] [William Jay] [Entered: 08/14/2026 05:21 PM] |
| Filing 54 Notice of Related Case Information for Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 08/14/2026 by email, US mail. [1186580] [26-1581] [William Jay] [Entered: 08/14/2026 05:09 PM] |
|
Filing 53
ORDER The motion to withdraw, ECF No. 52, is granted. The motion to file an amicus brief, ECF No. 50, is withdrawn. Moderna, Inc. and ModernaTX, Inc. may file their reply brief no later than 21 days from the date of entry of this order. Service as of this date by the Clerk of Court. [1182375] [LMS] [Entered: 07/29/2026 09:46 AM]
|
| Filing 52 MOTION of The Honorable Lamar Smith to withdraw [ # 50 ] motion to extend time to file brief. Service: 07/28/2026 by email, US mail. [1182287] [26-1581] [Matthew Dowd] [Entered: 07/28/2026 04:14 PM] |
|
Filing 51
ORDER The briefing schedule is stayed pending the court's consideration of the motion [ # 50 ]. Any opposition to the motion is due no later than seven days from the date of entry of this order. Any reply is due no later than three days from the date of service of any response. Service as of this date by the Clerk of Court. [1181460] [LMS] [Entered: 07/23/2026 02:59 PM]
|
| Filing 50 MOTION of the Honorable Lamar Smith to extend the time to 07/22/2026 to file brief. Service: 07/22/2026 by email, US mail. [1181176] [26-1581] Withdrawn pursuant to court order [ # 53 ] [Matthew Dowd] [Entered: 07/22/2026 08:26 PM] |
| Filing 49 Certificate of Interest for the Honorable Lamar Smith. Service: 07/22/2026 by email, US mail. [1181174] [26-1581] [Matthew Dowd] [Entered: 07/22/2026 08:22 PM] |
| Filing 48 Entry of Appearance for Matthew J. Dowd; Robert J. Scheffel; Elliot A. Gee; Morris D. Young as counsel for Lamar Smith. Service: 07/22/2026 by email, US mail. [1181173] [26-1581] [Matthew Dowd] [Entered: 07/22/2026 08:20 PM] |
| Filing 47 MODIFIED ENTRY: AMICUS BRIEF FILED by A28 Therapeutics, Inc., AbbVie Inc., Archetype Therapeutics, Inc., Bayer HealthCare Pharmaceuticals Inc., Eloxx Pharmaceuticals, Inc., Elutia, Inc., JURA Bio, Inc., Novartis Pharmaceuticals Corporation and Yokina Biome, Inc.. Service: 07/15/2026 by email. [1179639]--[Edited 07/16/2026 by JCW - Reason: compliance review complete] [Chase Cobern] [Entered: 07/15/2026 07:20 PM] |
| Filing 46 MODIFIED ENTRY: AMICUS BRIEF FILED by 17 FORMER JUDGES, FORMER OFFICIALS, AND ACADEMIC SCHOLARS. Service: 07/15/2026 by email. [1179638]--[Edited 07/16/2026 by JCW - Reason: compliance review complete] [Marc Hankin] [Entered: 07/15/2026 07:19 PM] |
| Filing 45 Entry of Appearance for Chase A. Cobern; Michael C. Wilson; Alexander D. Jablonski; Steven G. Spears as counsel for Novartis Pharmaceuticals Corporation; AbbVie Inc.; Bayer Healthcare Pharmaceuticals Inc.; A28 Therapeutics, Inc.; JURA Bio, Inc.; Elutia, Inc.; Eloxx Pharmaceuticals, Inc.; Archetype Therapeutics, Inc.; Yokina Biome, Inc.. Service: 07/15/2026 by email, US mail. [1179635] [26-1581] [Chase Cobern] [Entered: 07/15/2026 07:13 PM] |
| Filing 44 MODIFIED ENTRY: AMICUS BRIEF FILED by Bayh-Doyle Coalition. Service: 07/15/2026 by email. [1179618]--[Edited 07/17/2026 by JCW - Reason: compliance review complete] [Oleg Khariton] [Entered: 07/15/2026 05:15 PM] |
| Filing 43 Entry of Appearance for Brian P. O'Shaughnessy; Oleg Khariton as counsel for The Bayh-Dole Coalition. Service: 07/15/2026 by email, US mail. [1179617] [26-1581] [Oleg Khariton] [Entered: 07/15/2026 05:04 PM] |
| Filing 42 MODIFIED ENTRY: AMICUS BRIEF FILED by USIJ. Service: 07/15/2026 by email. [1179517]--[Edited 07/16/2026 by JCW - Reason: compliance review complete] [Robert Taylor] [Entered: 07/15/2026 02:54 PM] |
| Filing 41 Certificate of Interest for Alliance of U.S. Startups and Inventors for Jobs (USIJ). Service: 07/15/2026 by email. [1179514] [26-1581] [Robert Taylor] [Entered: 07/15/2026 02:53 PM] |
| Filing 40 Entry of Appearance for Robert P. Taylor as counsel for Alliance of U.S. Startups and Inventors for Jobs (USIJ). Service: 07/15/2026 by email. [1179513] [26-1581] [Robert Taylor] [Entered: 07/15/2026 02:52 PM] |
| Filing 39 MODIFIED ENTRY: AMICUS BRIEF FILED by Northwestern University. Service: 07/15/2026 by email. [1179509]--[Edited 07/16/2026 by JCW - Reason: compliance review complete] [Katherine Rhoades] [Entered: 07/15/2026 01:59 PM] |
| Filing 38 Certificate of Interest for Northwestern University. Service: 07/15/2026 by email, US mail. [1179508] [26-1581] [Katherine Rhoades] [Entered: 07/15/2026 01:56 PM] |
| Filing 37 Entry of Appearance for Katherine E. Rhoades; Rebecca T. Horwitz; Meg E. Fasulo as counsel for Northwestern University. Service: 07/15/2026 by email, US mail. [1179505] [26-1581] [Katherine Rhoades] [Entered: 07/15/2026 01:54 PM] |
| Filing 36 Entry of Appearance for Marc E. Hankin as counsel for 17 FORMER JUDGES, FORMER OFFICIALS, AND ACADEMIC SCHOLARS AS AMICI CURIAE. Service: 07/15/2026 by email, US mail. [1179455] [26-1581] [Marc Hankin] [Entered: 07/15/2026 11:04 AM] |
| Filing 35 Entry of Appearance for Andrew L. Schlafly as counsel for Eagle Forum Education & Legal Defense Fund. Service: 07/14/2026 by email, US mail. [1179220] [26-1581] [Andrew Schlafly] [Entered: 07/14/2026 12:15 PM] |
| Filing 34 MODIFIED ENTRY: AMICUS BRIEF FILED by Eagle Forum Education & Legal Defense Fund. Service: 07/14/2026 by email. [1179108]--[Edited 07/16/2026 by JCW - Reason: compliance review complete] [Andrew Schlafly] [Entered: 07/14/2026 01:33 AM] |
| Filing 33 MODIFIED ENTRY: RESPONSE BRIEF FILED by Appellees Arbutus Biopharma Corporation and Genevant Sciences, GmbH. Service: 07/08/2026 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1178397] --[Edited 07/09/2026 by JCW - Reason: compliance review complete] [David Berl] [Entered: 07/08/2026 09:58 PM] |
| Filing 32 Notice of Related Case Information for Appellees Arbutus Biopharma Corporation and Genevant Sciences, GmbH. Service: 07/08/2026 by email, US mail. [1178396] [26-1581] [David Berl] [Entered: 07/08/2026 09:56 PM] |
| Filing 31 Entry of Appearance for McKaye L. Neumeister; Brad Hinshelwood as counsel for Amicus Curiae US. Service: 06/22/2026 by email. [1174988] [26-1581] [McKaye Neumeister] [Entered: 06/22/2026 03:22 PM] |
| Filing 30 REMINDER : All amici counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(c) and Fed. Cir. R. 47.3 to promptly submit an Entry of Appearance (EOA). Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [1174835] [JSP] [Entered: 06/22/2026 08:55 AM] |
| Filing 29 MODIFIED ENTRY: AMICUS BRIEF FILED by US. Service: 06/19/2026 by email. [1174799]--[Edited 06/22/2026 by JSP - compliance review complete] [Bradley Hinshelwood] [Entered: 06/19/2026 04:29 PM] |
| Filing 71 AMICUS BRIEF FILED by AIPLA. Service: 06/05/2026 by email. [1189191] [MJL] [Entered: 08/26/2026 02:18 PM] |
|
Filing 28
ORDER filed granting motion for leave to file an amicus curiae brief [ # 18 ]. The amicus brief, ECF No. 18-2, is accepted for filing. Service as of this date by the Clerk of Court. [1174747] [NL] [Entered: 06/18/2026 03:57 PM]
|
| Filing 27 Notice of Related Case Information for Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 06/16/2026 by email. [1174106] [26-1581] [William Jay] [Entered: 06/16/2026 01:14 PM] |
| Filing 26 6 paper copies of Doc. No. [ # 21 ] received from Amicus Curiae Dr. Matthew Hepburn. [1173158] [CDL] [Entered: 06/10/2026 03:57 PM] |
| Filing 25 Entry of Appearance for Brian Pandya; Seth Rokosky as counsel for Amicus Curiae National Association of Manufacturers. Service: 06/08/2026 by email. [1172337] [26-1581] [Brian Pandya] [Entered: 06/08/2026 10:34 AM] |
|
Filing 24
ORDER Any opposition to the motion [ # 18 ] is due no later than seven days from the date of entry of this order. Any reply is due no later than three days from the date of service of any response. Service as of this date by the Clerk of Court. [1172211] [NL] [Entered: 06/05/2026 04:37 PM]
|
| Filing 23 REMINDER : All amici counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(c) and Fed. Cir. R. 47.3 to promptly submit an Entry of Appearance (EOA). Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [1172186] [JSP] [Entered: 06/05/2026 04:00 PM] |
| Filing 22 MODIFIED ENTRY: AMICUS BRIEF FILED by National Association of Manufacturers. Service: 06/05/2026 by email. [1172167]--[Edited 06/05/2026 by JSP - compliance review complete] [Brian Pandya] [Entered: 06/05/2026 03:32 PM] |
| Filing 21 MODIFIED ENTRY: AMICUS BRIEF FILED by Dr. Matthew Hepburn. Service: 06/05/2026 by email. [1172047]--[Edited 06/05/2026 by JSP - compliance review complete]--[Edited 06/05/2026 by JSP] [Thomas Saunders] [Entered: 06/05/2026 12:04 PM] |
| Filing 20 Certificate of Interest for Dr. Matthew Hepburn. Service: 06/05/2026 by email. [1172046] [26-1581] [Thomas Saunders] [Entered: 06/05/2026 12:03 PM] |
| Filing 19 Entry of Appearance for Thomas G. Saunders; Maria Elizabeth Trujillo as counsel for Dr. Matthew Hepburn. Service: 06/05/2026 by email. [1172043] [26-1581] [Thomas Saunders] [Entered: 06/05/2026 12:02 PM] |
| Filing 18 MOTION of American Intellectual Property Law Association for leave to file an amicus curiae brief. Service: 06/05/2026 by email. [1171982] [26-1581] [Richard Matthews] [Entered: 06/05/2026 10:08 AM] |
| Filing 17 Certificate of Interest for American Intellectual Property Law Association. Service: 06/05/2026 by email. [1171975] [26-1581] [Richard Matthews] [Entered: 06/05/2026 10:01 AM] |
| Filing 16 Entry of Appearance for Richard T. Matthews; Clinton H. Brannon; Salvatore Anastasi as counsel for American Intellectual Property Law Association. Service: 06/05/2026 by email. [1171973] [26-1581] [Richard Matthews] [Entered: 06/05/2026 10:00 AM] |
| Filing 15 MODIFIED ENTRY: AMICUS BRIEF FILED by Texas Conservative Coalition Research Institute. Service: 06/05/2026 by email. [1171954]--[Edited 06/05/2026 by JSP - compliance review complete] [Russell Withers] [Entered: 06/05/2026 09:26 AM] |
|
Filing 14
ORDER filed granting the motion to extend time to file brief [ # 12 ] to the extent that the United States's amicus brief is due no later than June 22, 2026. Service as of this date by the Clerk of Court. [1171256] [LMS] [Entered: 06/03/2026 11:57 AM]
|
| Filing 13 MODIFIED ENTRY: OPENING BRIEF FILED by Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 05/29/2026 by email. Unless ordered otherwise, any responsive deadline runs from the date of service of this brief. See Fed. Cir. R. 31. [1170413] --[Edited 06/01/2026 by JSP - compliance review complete] [William Jay] [Entered: 05/29/2026 07:59 PM] |
| Filing 12 MOTION of United States to extend the time to 06/22/2026 to file brief. Service: 05/29/2026 by email. [1170407] [26-1581] [McKaye Neumeister] [Entered: 05/29/2026 07:03 PM] |
| Filing 11 Notice of Related Case Information for Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 05/29/2026 by email. [1170402] [26-1581] [William Jay] [Entered: 05/29/2026 06:19 PM] |
| Filing 10 Certificate of Interest for Appellees Arbutus Biopharma Corporation and Genevant Sciences, GmbH. Service: 05/12/2026 by email. [1166562] [26-1581] [David Berl] [Entered: 05/12/2026 01:45 PM] |
| Filing 9 Notice of Related Case Information for Appellees Arbutus Biopharma Corporation and Genevant Sciences, GmbH. Service: 05/12/2026 by email. [1166560] [26-1581] [David Berl] [Entered: 05/12/2026 01:43 PM] |
| Filing 8 Docketing Statement for the Appellees Arbutus Biopharma Corporation and Genevant Sciences, GmbH. Service: 05/12/2026 by email. [1166557] [26-1581] [David Berl] [Entered: 05/12/2026 01:42 PM] |
| Filing 7 Entry of Appearance for David I. Berl as counsel for Appellees Arbutus Biopharma Corporation and Genevant Sciences, GmbH. Service: 05/12/2026 by email. [1166551] [26-1581] [David Berl] [Entered: 05/12/2026 01:37 PM] |
| Filing 6 Notice to Appellees Arbutus Biopharma Corporation and Genevant Sciences, GmbH: The record of this case indicates that no Entry of Appearance under FCR 47.3(b), and Certificate of Interest under FCR 47.4 have been filed. Failure to file required documents may result in dismissal or other action as deemed appropriate by the court. See FCR 25(h). Service as of this date by the Clerk of Court. [1166114] [JSP] [Entered: 05/11/2026 11:22 AM] |
| Filing 5 Docketing Statement for the Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 04/13/2026 by email. [1159160] [26-1581] [William Jay] [Entered: 04/13/2026 12:49 PM] |
| Filing 4 Notice of Related Case Information for Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 04/07/2026 by email. [1158180] [26-1581] [William Jay] [Entered: 04/07/2026 05:05 PM] |
| Filing 3 Certificate of Interest for Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 04/07/2026 by email. [1158177] [26-1581] [William Jay] [Entered: 04/07/2026 05:00 PM] |
| Filing 2 Entry of Appearance for William M. Jay; Jaime A. Santos; Jordan Bock; Gabriel Ferrante; Joseph Landry; James F. Hurst; Mark Charles McLennan as counsel for Appellants Moderna, Inc. and ModernaTX, Inc.. Service: 04/07/2026 by email. [1158176] [26-1581] [William Jay] [Entered: 04/07/2026 04:56 PM] |
| Filing 1 Appeal docketed. Received: 03/25/2026. [1156083] Entry of Appearance is due on 04/13/2026. Certificate of Interest is due on 04/13/2026. Docketing Statement is due on 04/13/2026. Appellant's brief is due on 05/29/2026. [JSP] [Entered: 03/30/2026 09:21 AM] |
Access additional case information on PACER
Access the Case Summary and Docket Report to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
